Safety, Tolerability, Efficacy, Pharmacokinetics Profile and Immunogenicity of HS-20117 in Combination with Other Drugs in Advanced Solid Tumors, a Phase Ib Clinical Trial
Latest Information Update: 09 Oct 2024
At a glance
- Drugs PM 1080 (Primary) ; Carboplatin; Cisplatin; Fluorouracil; HS-20093; Pemetrexed
- Indications Colorectal cancer; Non-small cell lung cancer; Solid tumours
- Focus Adverse reactions
- Sponsors Hansoh BioMedical R&D Company
- 09 Oct 2024 New trial record